Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

MRK.US Logo

MRK.US - Current Price

$109.19

Company Information

▼
Company Name
Merck & Company Inc
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
ISIN: US58933Y1055
CIK: 0000310158
CUSIP: 589339209
Currency: USD
Full Time Employees: 73,000
Phone: 908 740 4000
Website: https://www.merck.com
Fiscal Year End: December
IPO Date: Jan 13, 1978
Description:

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Address:

126 East Lincoln Avenue, Rahway, NJ, United States, 07065

Directors & Officers

▼
Name Title Year Born
Mr. Robert M. Davis J.D. Chairman, President & CEO 1967
Ms. Caroline A. Litchfield Executive VP & CFO 1970
Ms. Betty D. Larson Executive VP & Chief Human Resources Officer 1976
Mr. Richard R. DeLuca Jr. Executive VP & President of Merck Animal Health 1963
Dr. Dean Y. Li M.D., Ph.D. Executive VP & President of Merck Research Laboratories 1964
Mr. Dalton E. Smart III Senior VP of Finance, Principal Accounting Officer & Global Controller 1967
Mr. David Michael Williams Executive VP and Chief Information & Digital Officer 1970
Mr. Peter Dannenbaum Vice President of Investor Relations NA
Ms. Jennifer L. Zachary J.D. Executive VP & General Counsel 1979
Mr. Sanat Chattopadhyay Executive VP & President of Merck Manufacturing Division 1960

Shares Statistics

▼
Shares Outstanding: 2.48B
Shares Float: 2.48B
% Insiders: 5.80%
% Institutions: 8,010.00%
Short % Float: 1.67%

Valuation Metrics

▼
Enterprise Value: $297.50B
Trailing P/E: 14.44
Forward P/E: 11.76

Financial Highlights

▼
Market Cap: $272.73B
EBITDA: $31.52B
P/E Ratio: $14.44
PEG Ratio: $1.16
Book Value: $20.85
Dividend/Share: $3.20
Dividend Yield: 2.90%
Earnings/Share: $7.56
Profit Margin: 29.63%
Operating Margin: 40.80%
ROA (TTM): 13.76%
ROE (TTM): 39.49%
Revenue (TTM): $64.23B
Revenue/Share (TTM): $25.56
Earnings Growth (YOY): 87.00%
Revenue Growth (YOY): 3.70%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2026 N/A N/A N/A N/A
Jun 30, 2026 N/A N/A N/A N/A
Mar 31, 2026 N/A N/A N/A N/A
Dec 31, 2025 N/A N/A N/A N/A
Sep 30, 2025 2.58 2.37 N/A 886.08%
Jun 30, 2025 2.13 2.03 N/A 492.61%
Mar 31, 2025 2.22 2.14 N/A 373.83%
Dec 31, 2024 1.72 1.67 N/A 299.40%
Sep 30, 2024 1.57 1.57 N/A 0.00%
Jun 30, 2024 2.28 2.15 N/A 604.65%
Mar 31, 2024 2.07 1.88 N/A 1,010.64%
Dec 31, 2023 0.03 -0.11 N/A 12,727.27%
Sep 30, 2023 2.13 1.95 N/A 923.08%
Jun 30, 2023 -2.06 -2.18 N/A 550.46%
Mar 31, 2023 1.40 1.32 N/A 606.06%
Dec 31, 2022 1.62 1.54 N/A 519.48%
Sep 30, 2022 1.85 1.71 N/A 818.71%
Jun 30, 2022 1.87 1.70 N/A 1,000.00%
Mar 31, 2022 2.14 1.83 N/A 1,693.99%
Dec 31, 2021 1.80 1.53 N/A 1,764.71%
Sep 30, 2021 1.75 1.55 N/A 1,290.32%
Jun 30, 2021 1.31 1.31 N/A 0.00%
Mar 31, 2021 1.40 1.63 N/A -1,411.04%
Dec 31, 2020 1.32 1.38 N/A -434.78%
Sep 30, 2020 1.74 1.44 N/A 2,083.33%
Jun 30, 2020 1.37 1.04 N/A 3,173.08%
Mar 31, 2020 1.50 1.34 N/A 1,194.03%
Dec 31, 2019 1.16 1.15 N/A 86.96%
Sep 30, 2019 1.51 1.24 N/A 2,177.42%
Jun 30, 2019 1.30 1.16 N/A 1,206.90%
Mar 31, 2019 1.22 1.06 N/A 1,509.43%
Dec 31, 2018 1.04 1.03 N/A 97.09%
Sep 30, 2018 1.19 1.14 N/A 438.60%
Jun 30, 2018 1.06 1.03 N/A 291.26%
Mar 31, 2018 1.05 1.00 N/A 500.00%
Dec 31, 2017 0.98 0.94 N/A 425.53%
Sep 30, 2017 1.11 1.03 N/A 776.70%
Jun 30, 2017 1.01 0.87 N/A 1,609.20%
Mar 31, 2017 0.88 0.83 N/A 602.41%
Dec 31, 2016 0.89 0.89 N/A 0.00%
Sep 30, 2016 1.07 0.99 N/A 808.08%
Jun 30, 2016 0.93 0.91 N/A 219.78%
Mar 31, 2016 0.89 0.85 N/A 470.59%
Dec 31, 2015 0.93 0.91 N/A 219.78%
Sep 30, 2015 0.96 0.91 N/A 549.45%
Jun 30, 2015 0.86 0.81 N/A 617.28%
Mar 31, 2015 0.85 0.75 N/A 1,333.33%
Dec 31, 2014 0.87 0.85 N/A 235.29%
Sep 30, 2014 0.90 0.88 N/A 227.27%
Jun 30, 2014 0.85 0.81 N/A 493.83%
Mar 31, 2014 0.88 0.79 N/A 1,139.24%
Dec 31, 2013 0.88 0.89 N/A -112.36%
Sep 30, 2013 0.92 0.88 N/A 454.55%
Jun 30, 2013 0.84 0.83 N/A 120.48%
Mar 31, 2013 0.85 0.79 N/A 759.49%
Dec 31, 2012 0.83 0.81 N/A 246.91%
Sep 30, 2012 0.95 0.92 N/A 326.09%
Jun 30, 2012 1.05 1.01 N/A 396.04%
Mar 31, 2012 0.56 N/A N/A N/A
Dec 31, 2011 0.97 0.95 N/A 210.53%
Sep 30, 2011 0.94 0.91 N/A 329.67%
Jun 30, 2011 0.95 0.95 N/A 0.00%
Mar 31, 2011 0.92 0.84 N/A 952.38%
Dec 31, 2010 0.88 0.83 N/A 602.41%
Sep 30, 2010 0.85 0.82 N/A 365.85%
Jun 30, 2010 0.86 0.83 N/A 361.45%
Mar 31, 2010 0.83 0.75 N/A 1,066.67%
Dec 31, 2009 0.79 0.79 N/A 0.00%
Sep 30, 2009 0.90 0.82 N/A 975.61%
Jun 30, 2009 0.83 0.77 N/A 779.22%
Mar 31, 2009 0.74 0.77 N/A -389.61%
Dec 31, 2008 0.87 0.74 N/A 1,756.76%
Sep 30, 2008 0.80 0.79 N/A 126.58%
Jun 30, 2008 0.86 0.83 N/A 361.45%
Mar 31, 2008 0.89 0.86 N/A 348.84%
Dec 31, 2007 0.80 0.74 N/A 810.81%
Sep 30, 2007 0.75 0.69 N/A 869.57%
Jun 30, 2007 0.82 0.72 N/A 1,388.89%
Mar 31, 2007 0.84 0.84 N/A 0.00%
Dec 31, 2006 0.50 0.50 N/A 0.00%
Sep 30, 2006 0.51 0.50 N/A 200.00%
Jun 30, 2006 0.73 0.65 N/A 1,230.77%
Mar 31, 2006 0.78 0.72 N/A 833.33%
Dec 31, 2005 0.64 0.62 N/A 322.58%
Sep 30, 2005 0.65 0.62 N/A 483.87%
Jun 30, 2005 0.62 0.62 N/A 0.00%
Mar 31, 2005 0.62 0.59 N/A 508.47%
Dec 31, 2004 0.50 0.50 N/A 0.00%
Sep 30, 2004 0.60 0.71 N/A -1,549.30%
Jun 30, 2004 0.79 0.79 N/A 0.00%
Mar 31, 2004 0.73 0.72 N/A 138.89%
Dec 31, 2003 0.62 0.62 N/A 0.00%
Sep 30, 2003 0.83 0.85 N/A -235.29%
Jun 30, 2003 0.83 0.84 N/A -119.05%
Mar 31, 2003 0.76 0.76 N/A 0.00%
Dec 31, 2002 0.83 0.83 N/A 0.00%
Sep 30, 2002 0.83 0.83 N/A 0.00%
Jun 30, 2002 0.77 0.77 N/A 0.00%
Mar 31, 2002 0.71 0.71 N/A 0.00%
Dec 31, 2001 0.81 0.80 N/A 125.00%
Sep 30, 2001 0.84 0.83 N/A 120.48%
Jun 30, 2001 0.78 0.78 N/A 0.00%
Mar 31, 2001 0.71 0.71 N/A 0.00%
Dec 31, 2000 0.75 0.75 N/A 0.00%
Sep 30, 2000 0.78 0.73 N/A 684.93%
Jun 30, 2000 0.73 0.69 N/A 579.71%
Mar 31, 2000 0.63 0.62 N/A 161.29%
Dec 31, 1999 0.66 0.66 N/A 0.00%
Sep 30, 1999 0.64 0.64 N/A 0.00%
Jun 30, 1999 0.61 0.61 N/A 0.00%
Mar 31, 1999 0.55 0.54 N/A 185.19%
Dec 31, 1998 0.58 0.58 N/A 0.00%
Sep 30, 1998 0.56 0.56 N/A 0.00%
Jun 30, 1998 0.56 0.54 N/A 370.37%
Mar 31, 1998 0.48 0.48 N/A 0.00%
Dec 31, 1997 0.52 0.51 N/A 196.08%
Sep 30, 1997 0.50 0.50 N/A 0.00%
Jun 30, 1997 0.48 0.48 N/A 0.00%
Mar 31, 1997 0.42 0.42 N/A 0.00%
Dec 31, 1996 0.44 0.43 N/A 232.56%
Sep 30, 1996 0.42 0.41 N/A 243.90%
Jun 30, 1996 0.40 0.40 N/A 0.00%
Mar 31, 1996 0.35 0.35 N/A 0.00%
Dec 31, 1995 0.35 0.35 N/A 0.00%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $13.24B $N/A $117.11B $70.73B $46.31B
2023-12-31 $6.84B $N/A $106.68B $69.04B $37.58B
2022-12-31 $12.69B $N/A $109.16B $63.10B $45.99B
2021-12-31 $8.10B $N/A $105.69B $67.44B $38.18B
2020-12-31 $8.05B $N/A $91.59B $66.18B $25.32B
2019-12-31 $9.68B $N/A $84.40B $58.40B $25.91B
2018-12-31 $7.97B $N/A $82.64B $55.76B $26.70B
2017-12-31 $6.09B $N/A $87.87B $53.30B $34.34B
2016-12-31 $6.52B $N/A $95.38B $55.07B $40.09B
2015-12-31 $8.52B $N/A $101.68B $56.91B $44.68B
2014-12-31 $7.44B $N/A $98.17B $49.38B $48.65B
2013-12-31 $15.62B $N/A $105.65B $53.32B $49.77B
2012-12-31 $13.45B $N/A $106.13B $50.67B $53.02B
2011-12-31 $13.53B $N/A $105.13B $48.19B $54.52B
2010-12-31 $10.90B $N/A $105.78B $48.98B $54.38B
2009-12-31 $9.31B $N/A $112.31B $50.83B $59.06B
2008-12-31 $4.37B $N/A $47.20B $26.03B $18.76B
2007-12-31 $5.34B $N/A $48.35B $27.76B $18.18B
2006-12-31 $5.91B $N/A $44.57B $24.60B $17.56B
2005-12-31 $9.59B $N/A $44.85B $24.46B $17.98B
2004-12-31 $2.88B $N/A $42.57B $22.88B $17.29B
2003-12-31 $1.20B $N/A $40.59B $21.10B $15.58B
2002-12-31 $2.24B $N/A $47.56B $24.43B $18.20B
2001-12-31 $2.14B $N/A $44.02B $23.13B $16.05B
2000-12-31 $2.54B $N/A $39.91B $20.06B $14.83B
1999-12-31 $2.02B $N/A $35.63B $18.93B $13.24B
1998-12-31 $2.61B $N/A $31.85B $15.35B $12.80B
1997-12-31 $1.13B $N/A $25.74B $11.98B $12.59B
1996-12-31 $1.35B $N/A $24.29B $10.01B $11.97B
1995-12-31 $1.85B $N/A $23.83B $9.81B $11.74B
1994-12-31 $1.60B $N/A $21.86B $9.51B $11.14B
1993-12-31 $829.40M $N/A $19.93B $8.76B $10.02B
1992-12-31 $575.10M $N/A $11.09B $5.46B $5.00B
1991-12-31 $797.90M $N/A $9.50B $3.99B $4.92B
1990-12-31 $806.40M $N/A $8.03B $3.65B $3.83B
1989-12-31 $685.10M $N/A $6.76B $2.73B $3.52B
1988-12-31 $1.55B $N/A $6.13B $3.27B $2.86B
1987-12-31 $1.15B $N/A $5.68B $3.56B $2.12B
1986-12-31 $965.80M $N/A $5.11B $2.54B $2.57B
1985-12-31 $842.00M $N/A $4.90B $2.27B $2.63B

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 29, 2025 N/A N/A N/A N/A N/A N/A
Sep 23, 2025 N/A N/A N/A N/A N/A N/A
Aug 28, 2025 N/A N/A N/A N/A N/A N/A
Aug 22, 2025 N/A N/A N/A N/A N/A N/A
Aug 14, 2025 N/A N/A N/A N/A N/A N/A
Aug 05, 2025 N/A N/A N/A N/A N/A N/A
Aug 04, 2025 N/A N/A N/A N/A N/A N/A
Aug 04, 2025 N/A N/A N/A N/A N/A N/A
Jul 11, 2025 N/A N/A N/A N/A N/A N/A
Jul 01, 2025 N/A N/A N/A N/A N/A N/A
Jun 27, 2025 N/A N/A N/A N/A N/A N/A
Jun 24, 2025 N/A N/A N/A N/A N/A N/A
Jun 23, 2025 N/A N/A N/A N/A N/A N/A
Jun 20, 2025 N/A N/A N/A N/A N/A N/A
Jun 16, 2025 N/A N/A N/A N/A N/A N/A
Jun 13, 2025 N/A N/A N/A N/A N/A N/A
May 30, 2025 N/A N/A N/A N/A N/A N/A
May 28, 2025 N/A N/A N/A N/A N/A N/A
May 19, 2025 N/A N/A N/A N/A N/A N/A
May 19, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist